Subscribe to this column
Edward P. Balaban, FACP, DO, FASCO
Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).
Dec 02, 2021
The AMA House of Delegates adopted a resolution to remain committed with increased efforts against the resumption of the sequestration payment applied to all Medicare fee-for-service claims.
Jun 30, 2021
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models.
Dec 02, 2020
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
Jun 10, 2020
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
Dec 03, 2019
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Latest Blogs